NMN vs NR for Anti-Aging: Which NAD+ Booster Is Better According to Research

Introduction: The NAD+ Question That Has the Longevity World Divided

#

If you have spent any time in the anti-aging or longevity space, you have almost certainly encountered two acronyms: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). Both are precursors to NAD+ (nicotinamide adenine dinucleotide), a coenzyme that plays a central role in cellular energy production, DNA repair, and the activity of longevity-associated enzymes called sirtuins. And both have attracted enormous attention from researchers, biohackers, and supplement companies alike.

The core promise is simple: NAD+ levels decline significantly as we age, and restoring those levels might slow or even partially reverse certain aspects of biological aging. The question that divides researchers, consumers, and supplement manufacturers is which precursor does the job better.

Harvard geneticist David Sinclair put NMN on the map with his lab’s research on sirtuins and aging. ChromaDex, the company behind the patented NR product Niagen, has funded the largest body of human clinical trials on any NAD+ precursor. Meanwhile, the FDA spent nearly three years deciding whether NMN could even be sold as a supplement in the United States.

This article examines everything the published research tells us about NMN and NR. We will cover the biochemistry, the human clinical trials, the dosing protocols, the regulatory landscape, the quality concerns, the cost differences, and what you can realistically expect from supplementation. We will also discuss non-supplement strategies for boosting NAD+ that are often overlooked in the conversation.

This is not a simple “which is better” answer. The honest truth is more nuanced than most supplement marketing would have you believe.

Watch Our Video Review

#

What Is NAD+ and Why Does It Matter for Aging?

#

NAD+ stands for nicotinamide adenine dinucleotide, and calling it important is an understatement. It is found in every living cell and is essential for hundreds of enzymatic reactions that keep you alive. Without adequate NAD+, your cells cannot efficiently convert food into energy, repair damaged DNA, regulate gene expression, or maintain proper cellular communication.

The Core Functions of NAD+

#

NAD+ serves two primary biochemical roles. First, it acts as a coenzyme in redox reactions, shuttling electrons in metabolic pathways like glycolysis, the citric acid cycle, and oxidative phosphorylation. These are the processes your mitochondria use to produce ATP, the energy currency of cells. Without NAD+, mitochondrial function deteriorates, and cellular energy production declines.

Second, NAD+ serves as a substrate (meaning it gets consumed) by several families of enzymes that are directly relevant to aging:

Sirtuins (SIRT1-SIRT7): These are a family of seven proteins that regulate cellular health by removing acetyl groups from other proteins. They influence DNA repair, inflammation, mitochondrial biogenesis, circadian rhythm, and stress resistance. Sirtuins require NAD+ to function. When NAD+ levels drop, sirtuin activity drops with it. David Sinclair’s lab at Harvard was among the first to identify the critical role of NAD+ biosynthesis in regulating sirtuin function and lifespan, first in yeast and then in mammals.

PARPs (Poly-ADP-Ribose Polymerases): PARP enzymes detect and repair DNA damage. When DNA damage increases (as it does with aging and environmental stress), PARP activity increases, consuming large amounts of NAD+ in the process. PARP1 in particular is a major NAD+ consumer, and its increased activity with age contributes to the depletion of the cellular NAD+ pool.

CD38/CD157 Ectoenzymes: These are NAD+-consuming enzymes expressed on immune cells and other tissues. CD38 is now widely regarded as the primary NADase (NAD-destroying enzyme) in mammalian tissues. Research published in Cell Metabolism showed that CD38 expression increases dramatically with age, rising approximately 2.5-fold in liver, adipose tissue, and skeletal muscle, and up to 6-fold in the spleen. This increase in CD38 activity is considered a dominant driver of age-related NAD+ decline.

How Much NAD+ Do You Lose With Age?

#

The decline is substantial. By the time a mouse or human reaches middle age, tissue NAD+ levels have typically fallen to approximately half of what they were in youth. This decline is not just a biomarker of aging; researchers believe it actively contributes to the aging process by impairing mitochondrial function, reducing DNA repair capacity, increasing inflammation, and disrupting metabolic regulation.

The decline is driven by a combination of factors: increased NAD+ consumption by CD38, PARP, and other enzymes; decreased activity of NAD+ biosynthetic enzymes like NAMPT (nicotinamide phosphoribosyltransferase); and chronic low-grade inflammation that further accelerates NAD+ degradation.

This is the biological rationale for NAD+ precursor supplementation. If declining NAD+ contributes to aging, then restoring NAD+ levels with precursors like NMN or NR might theoretically slow or partially reverse age-related decline.

NMN vs NR: The Biochemistry

#

Both NMN and NR are forms of vitamin B3, and both ultimately get converted into NAD+ inside your cells. But they are not identical molecules, and they follow somewhat different metabolic pathways to reach that endpoint.

Molecular Structure

#

NMN (nicotinamide mononucleotide) consists of a nicotinamide group, a ribose sugar, and a phosphate group. Its molecular weight is approximately 334 daltons.

NR (nicotinamide riboside) is essentially the same molecule minus the phosphate group. It consists of a nicotinamide group bonded to a ribose sugar. Its molecular weight is approximately 255 daltons, making it the smaller of the two molecules.

This size difference matters for absorption and cellular uptake, though the practical significance has been debated extensively.

The NAD+ Biosynthesis Pathways

#

Your body can produce NAD+ through several pathways:

The Salvage Pathway (most important for supplementation): This is the dominant pathway for maintaining NAD+ levels in most tissues. In this pathway, nicotinamide (NAM, regular vitamin B3) is converted to NMN by the enzyme NAMPT, and then NMN is converted to NAD+ by NMNAT enzymes. This pathway recycles the nicotinamide generated when sirtuins, PARPs, and CD38 consume NAD+.

The Preiss-Handler Pathway: This converts nicotinic acid (niacin) to NAD+ through a series of steps involving NAPRT and NMNAT enzymes.

The De Novo Pathway: This synthesizes NAD+ from the amino acid tryptophan through a longer series of enzymatic reactions.

When you take NMN as a supplement, it is already one step ahead in the salvage pathway. It only needs conversion to NAD+ by NMNAT enzymes, which are widely expressed in tissues.

When you take NR as a supplement, it first needs to be phosphorylated (have a phosphate group added) by nicotinamide riboside kinases (NRK1 and NRK2) to become NMN, and then NMN is converted to NAD+ by NMNAT. So NR requires one additional enzymatic step compared to NMN.

The Cell Entry Question

#

One of the most debated points in the NMN vs NR discussion is how each molecule enters cells. NR, being smaller and lacking the charged phosphate group, can cross cell membranes more easily through equilibrative nucleoside transporters. For years, it was believed that NMN could not directly enter cells because of its larger size and the negative charge of its phosphate group.

However, in 2019, a study identified a specific NMN transporter called Slc12a8, which appears to facilitate direct NMN uptake in certain tissues, particularly in the small intestine. This finding, from Shin-ichiro Imai’s lab at Washington University, suggested that NMN might not always need to be converted to NR before entering cells.

But the picture is more complicated than either side acknowledges. Research published in Nature Communications showed that NRK1 (nicotinamide riboside kinase 1) is necessary and rate-limiting for the utilization of exogenous NR and NMN for NAD+ synthesis, suggesting that at least some NMN is dephosphorylated to NR extracellularly before being taken up by cells and re-phosphorylated back to NMN. A 2024 study in Science Advances examining the metabolic flux of orally administered NAD+ precursors found that a significant portion of both NMN and NR undergoes gut microbiota-mediated deamidation, with roughly 25-75% being converted to nicotinic acid before absorption.

The practical takeaway is that both molecules ultimately raise NAD+ levels through overlapping pathways, and neither has an overwhelmingly clear mechanistic advantage in terms of cellular delivery.

Human Clinical Trials: What the Evidence Actually Shows

#

This is where the rubber meets the road. Animal studies showed remarkable benefits for both NMN and NR, including improved metabolic health, enhanced physical performance, and extended lifespan in mice. But animal results frequently fail to translate to humans, so the human trial data is what matters most.

NMN Human Clinical Trials

#

The body of human NMN research has grown substantially in recent years, with multiple randomized, placebo-controlled trials now published.

Yoshino et al. (2021) - Washington University (Science): This was a landmark study. In the first randomized clinical trial of NMN in humans, 25 postmenopausal women with prediabetes received either 250 mg of NMN or placebo daily for 10 weeks. NMN supplementation improved muscle insulin sensitivity by approximately 25%, enhanced expression of genes involved in muscle structure and remodeling, and increased signaling through the mTOR pathway in skeletal muscle. Shin-ichiro Imai, who has studied NMN for nearly two decades, called this “one step toward the development of an anti-aging intervention.” However, the study was small and focused specifically on insulin sensitivity in a narrow population.

Yi et al. (2023) - Multicenter Trial: A randomized, multicenter, double-blind, placebo-controlled trial tested NMN at doses of 300 mg, 600 mg, and 900 mg daily. The study found NMN supplementation was safe and well tolerated at all doses, with clinical efficacy reaching its highest at 600 mg daily. Blood NAD+ levels increased significantly at all doses.

Huang et al. (2022) - Uthever NMN Trial (Frontiers in Aging): This multicentre, randomized, double-blind, placebo-controlled study evaluated 300 mg of NMN (Uthever brand) daily for 60 days in middle-aged and older adults. NMN supplementation safely increased blood NAD+ levels and showed improvements in walking endurance compared to placebo. No safety concerns were identified.

Igarashi et al. (2022) - Healthy Older Adults: A study in healthy older adults aged 65-75 years found that 250 mg/day of NMN for 12 weeks improved sleep quality and maintained walking speed, with significantly higher blood NAD+ levels in the NMN group compared to placebo.

Safety Evaluation (2022 - Scientific Reports): A safety-focused trial found that NMN was safe and well tolerated in healthy adult men and women at oral doses up to 1,250 mg once daily for up to 4 weeks, with no serious adverse events reported.

Meta-Analysis (August 2024): A systematic review and meta-analysis of 9 studies including 412 participants found that NMN supplementation had significant effects on muscle mass and gait speed, with positive efficacy in enhancing muscle function, reducing insulin resistance, and lowering aminotransferase levels in middle-aged and elderly individuals.

Glucose and Lipid Metabolism Meta-Analysis (2024): An additional meta-analysis of randomized controlled trials evaluating NMN’s effects on glucose and lipid metabolism in adults found that NMN supplementation had overall significant effects in elevating blood NAD+ levels. However, most clinically relevant metabolic outcomes did not reach statistical significance across the pooled data.

NR Human Clinical Trials

#

NR, largely through ChromaDex’s investment in its patented Niagen product, has the longest track record of published human clinical trials among NAD+ precursors.

Martens et al. (2018) - University of Colorado (Nature Communications): In a crossover trial with 24 lean, healthy middle-aged and older adults, 1,000 mg/day of NR for 6 weeks raised blood NAD+ by approximately 60%, lowered systolic blood pressure by a modest but significant amount, and reduced aortic stiffness. This was one of the first trials to demonstrate cardiovascular benefits of NAD+ precursor supplementation in humans.

Dollerup et al. (2018) - Danish Study: In insulin-resistant, obese men, 2,000 mg/day of NR for 12 weeks raised NAD+ metabolites in skeletal muscle and reduced circulating inflammatory cytokines, but did not significantly improve insulin sensitivity or glucose tolerance compared to placebo.

Elhassan et al. (2019) - University of Birmingham (Cell Reports): This trial showed that 1,000 mg/day of NR for 21 days significantly increased NAD+ metabolites in skeletal muscle of older men, with evidence of enhanced anti-inflammatory gene expression and reduced circulating inflammatory markers.

NICE Trial - Peripheral Artery Disease (2024 - Nature Communications): A Phase II randomized clinical trial demonstrated that NR supplementation improved functional mobility in individuals with peripheral artery disease (PAD). Among compliant participants, NR improved 6-minute walking distance by 31.0 meters compared to placebo.

Long-COVID Trial (2025 - eClinicalMedicine/Lancet): A randomized controlled trial evaluated NR (2,000 mg/day) for 24 weeks in individuals with long-COVID. The study assessed NAD+ levels, cognitive function, and symptom recovery. This represents one of the first controlled trials examining NAD+ precursors for post-viral syndromes.

Psoriasis and Inflammation (2023 - Cell Reports): A clinical study demonstrated that NR supplementation reduced inflammation in both healthy subjects and in immune cells derived from psoriasis patients, providing evidence for NR’s anti-inflammatory properties.

ChromaDex has reported at least nine published human clinical trials on Niagen, giving NR a meaningful lead in clinical evidence volume compared to NMN.

Head-to-Head Comparisons

#

Direct head-to-head comparisons of NMN and NR in human trials remain limited. However, a 2025 systematic review and comparison published in Food Frontiers analyzed the preclinical and clinical data for both compounds. Some comparative data suggests that 500 mg of NMN daily produced a 35% increase in whole-blood NAD+ levels after four weeks, compared to 22% for NR at comparable doses. However, these numbers come from separate studies with different populations, methodologies, and assay methods, making direct comparison problematic.

A 2025 systematic review and meta-analysis looking specifically at skeletal muscle mass and function concluded that current evidence does not support the use of either NMN or NR as effective interventions for improving muscle function and mass in adults above 60 years old.

Bioavailability: How Much Actually Gets Into Your Cells?

#

Bioavailability is one of the most critical and misunderstood aspects of the NMN vs NR comparison. Taking a supplement orally and having it reach your cells as intact NAD+ are very different things.

Oral NMN Bioavailability

#

When you swallow NMN, several things happen. The molecule enters your gastrointestinal tract, where it is exposed to digestive enzymes and gut bacteria. Research has shown that gut microbiota deamidates (chemically modifies) roughly 25-75% of orally taken NMN before it is absorbed, converting much of it to nicotinic acid, which then enters the Preiss-Handler pathway rather than the salvage pathway.

A 2022 pharmacokinetic study published in Frontiers in Nutrition confirmed that oral NMN administration safely and efficiently increases blood NAD+ levels in healthy subjects, with plasma NAD+ elevation detectable within hours and sustained for at least 24 hours after dosing. However, the efficiency of direct NMN absorption versus conversion to other metabolites before absorption remains an area of active research.

A pilot study found that combining NMN with BioPerine (piperine, a black pepper extract) increased serum NAD+ concentrations compared to NMN alone, suggesting that bioenhancers may improve NMN absorption.

Individual variability in NMN metabolism is substantial. Factors including gut microbiome composition, genetics, age, health status, and even time of day appear to influence how effectively any given person converts oral NMN into usable NAD+.

Oral NR Bioavailability

#

NR’s smaller molecular size and lack of a phosphate group give it some theoretical advantages in terms of membrane permeability. NR can cross cell membranes through equilibrative nucleoside transporters and does not require a specific transporter the way NMN may.

However, NR faces its own bioavailability challenges. Once absorbed, NR must be phosphorylated by NRK1 or NRK2 enzymes to become NMN before being converted to NAD+. This additional enzymatic step could potentially be rate-limiting in tissues with low NRK expression. NR is also subject to degradation by purine nucleoside phosphorylase, which can cleave it into nicotinamide before it reaches its target tissues.

ChromaDex has invested heavily in developing formulations to improve NR stability and absorption, including their Niagen crystalline form, which is designed to be more resistant to degradation than free-form NR.

Sublingual and Liposomal Formulations

#

Some companies market sublingual (under the tongue) NMN products, claiming that bypassing the digestive tract improves absorption. There is limited clinical evidence specifically supporting sublingual NMN delivery, though the theoretical rationale is sound: avoiding first-pass metabolism in the gut and liver could preserve more of the intact molecule.

Liposomal NMN formulations encapsulate the molecule in lipid vesicles, theoretically protecting it from digestive degradation and enhancing cellular uptake. Some manufacturers claim significantly improved bioavailability with liposomal delivery, though independent clinical data comparing liposomal to standard NMN capsules remains sparse.

Dosing Protocols: What the Research Supports

#

Dosing is where many consumers go wrong, either taking too little to have a meaningful effect or spending money on unnecessarily high doses. Here is what the clinical evidence supports for each compound.

NMN Dosing

#

The range of doses studied in human clinical trials spans from 125 mg to 1,250 mg daily:

• 250 mg/day: Used in the landmark Yoshino et al. (2021) trial at Washington University and the Igarashi et al. study in older adults. This dose improved insulin sensitivity and sleep quality, respectively, and raised blood NAD+ levels.
• 300 mg/day: Used in the Uthever NMN trial, where it raised NAD+ levels and improved walking endurance over 60 days.
• 500-600 mg/day: The multicenter Yi et al. trial found that 600 mg/day appeared to be the optimal dose for clinical efficacy. Many consumer products are standardized to 500 mg per serving.
• 900-1,250 mg/day: Higher doses have been tested for safety and shown to be well tolerated, but did not consistently produce proportionally greater benefits than moderate doses.

Practical recommendation: Based on the available evidence, 250-500 mg/day appears to be the sweet spot for most people. Starting at 250 mg and increasing to 500 mg if tolerated is a reasonable approach. Taking NMN in the morning may be preferable, as NAD+ levels naturally fluctuate with circadian rhythm.

NR Dosing

#

NR has been studied across a slightly broader dose range in clinical settings:

• 300 mg/day: The most commonly studied dose in early trials. Sufficient to meaningfully raise blood NAD+ levels.
• 500-1,000 mg/day: The range used in the Martens et al. cardiovascular trial and the Elhassan et al. muscle trial. 1,000 mg/day produced a roughly 60% increase in blood NAD+.
• 2,000 mg/day: Used in the long-COVID trial and the Dollerup et al. obesity trial. This is the highest dose extensively studied in humans and was well tolerated.

Practical recommendation: 300-1,000 mg/day is the evidence-supported range for NR. Tru Niagen, the most widely available NR product, is typically dosed at 300 mg per capsule. Many clinical benefits have been observed at 1,000 mg/day.

Timing and Duration

#

Both NMN and NR raise blood NAD+ levels within hours of oral administration, but sustained elevation requires consistent daily dosing. Studies show that NAD+ levels return to baseline within approximately one month of discontinuing supplementation, confirming that these are maintenance supplements rather than one-time interventions.

Most clinical trials showing positive outcomes ran for 6-12 weeks, suggesting that you should commit to at least 2-3 months of consistent use before evaluating whether supplementation is working for you.

The FDA Regulation Controversy Around NMN

#

The regulatory saga surrounding NMN in the United States is worth understanding, both for what it tells us about the supplement industry and for its practical implications for consumers.

The Timeline

#

In November 2022, the FDA informed two companies (SyncoZymes and Inner Mongolia Kingdomway Pharmaceutical) that NMN could not be marketed as a dietary supplement. The agency’s reasoning was that NMN had been “authorized for investigation as a new drug” by MetroBiotech, Inc. (co-founded by David Sinclair) before NMN was ever lawfully marketed as a dietary supplement. Under federal law, this meant NMN fell outside the definition of a dietary supplement.

This decision sent shockwaves through the supplement industry. Amazon temporarily removed NMN products from its marketplace. Consumers stockpiled existing supplies. Prices fluctuated wildly.

The Industry Response

#

The Natural Products Association (NPA) and the Alliance for Natural Health USA filed a Citizen Petition in March 2023, challenging the FDA’s position. When the FDA failed to respond satisfactorily, NPA filed a lawsuit against the agency in August 2024, arguing that NMN had been marketed as a dietary supplement in the United States as early as 2017, before the drug investigation authorization.

The Resolution

#

On September 29, 2025, the FDA reversed its position and confirmed that NMN is lawful for use in dietary supplements. The agency concluded that there was sufficient evidence that NMN had been marketed as a dietary supplement before it was authorized for drug investigation, satisfying the “race to market” provision under federal law.

However, the reversal came with important caveats. NMN remains classified as a New Dietary Ingredient (NDI), meaning companies must submit New Dietary Ingredient Notifications (NDINs) to the FDA before marketing NMN products. This requirement is intended to ensure that companies provide safety data and proper manufacturing documentation before selling NMN to consumers.

What This Means for NR

#

NR never faced the same regulatory challenge because ChromaDex proactively obtained Generally Recognized as Safe (GRAS) status for Niagen through a thorough regulatory process, including FDA notification. This gave NR a significant regulatory advantage during the period of NMN uncertainty and remains a point in its favor from a quality assurance standpoint.

Quality and Purity: A Serious Concern

#

Quality and purity are arguably the most important practical considerations when choosing between NMN and NR products, and the current state of the market is frankly alarming.

The Scope of the Problem

#

Independent testing has revealed widespread quality failures in the NMN supplement market. Research testing 22 leading NMN brands found that only 14% of products contained NMN at or above the labeled amount, 23% contained slightly less NMN than claimed (88-99% of label), and a staggering 64% contained NMN below the reportable limit, meaning less than 1% of the claimed amount. Some products contained no detectable NMN at all.

Testing by NOW Foods revealed additional problems: low potencies, fraudulent labeling, high microbial contamination, elevated heavy metal levels, and beef gelatin capsules mislabeled as vegetarian. Some suppliers have been caught selling ordinary nicotinamide (cheap vitamin B3) labeled as NMN.

Amazon marketplace products have been particularly problematic, with testing programs revealing poor quality, inadequate potency, and labeling that fell far short of actual amounts claimed. Fake certificates of analysis are highly prevalent in the NMN market.

NR Quality Landscape

#

The NR market is somewhat more controlled because ChromaDex’s Niagen is the dominant form used in quality products. ChromaDex holds patents on NR manufacturing processes and has invested in GMP (Good Manufacturing Practice) certified production. Products using genuine Niagen are required to meet ChromaDex’s quality standards.

However, some NR products sold under generic or unbranded formulations may not meet the same standards, and consumers should verify that any NR product they purchase contains the Niagen form.

How to Protect Yourself

#

When purchasing either NMN or NR, look for:

1. Third-party testing certificates: Legitimate certificates from recognized testing organizations (NSF International, USP, ConsumerLab, or Informed Sport) that verify potency and screen for contaminants including heavy metals, pesticides, and microbial contamination.
2. GMP certification: Products manufactured in GMP-certified facilities meet minimum quality standards for supplement production.
3. Transparent sourcing: Companies that disclose their ingredient sources and manufacturing processes are generally more trustworthy.
4. Reasonable pricing: Be suspicious of NMN products priced significantly below $0.50 per gram. Producing pharmaceutical-grade NMN involves substantial costs, and rock-bottom prices often indicate counterfeit or severely diluted products.
5. Established brands: Companies with a track record, transparent lab results, and responsive customer service teams are safer bets than unknown brands with only Amazon reviews.

Realistic Expectations: What NAD+ Boosters Can and Cannot Do

#

This section may be the most important in the entire article, because the gap between what NAD+ supplementation marketing implies and what the research actually demonstrates is significant.

What the Evidence Supports

#

Based on the current clinical trial data, here is what NMN and NR supplementation can reasonably be expected to do:

Raise blood NAD+ levels: This is well-established for both compounds. Multiple studies consistently show significant increases in blood NAD+ and related metabolites with oral supplementation. This is the primary mechanistic claim, and it holds up.

Modest improvements in specific metabolic markers: NMN has shown improvements in insulin sensitivity in prediabetic women, and some studies report modest improvements in lipid profiles, body weight, and blood pressure. NR has shown reductions in arterial stiffness and improvements in walking distance in PAD patients.

Potential improvements in sleep quality and physical function: Some studies report better sleep scores and maintained walking speed in older adults taking NMN.

Anti-inflammatory effects: NR in particular has shown reductions in circulating inflammatory markers in several trials.

What the Evidence Does Not Yet Support

#

Dramatic anti-aging effects in humans: Despite the compelling animal data and the plausible mechanisms, no human clinical trial has yet demonstrated that NMN or NR meaningfully slows the aging process, extends lifespan, or reverses biological age. The biomarker improvements are real but modest, and their long-term significance for healthspan and lifespan remains unknown.

Cognitive enhancement: While some trials are investigating NAD+ precursors for neurodegenerative conditions and long-COVID cognitive symptoms, no published trial has shown meaningful cognitive enhancement in healthy adults from NMN or NR supplementation.

Athletic performance gains: Despite some positive data on muscle function and walking endurance, a 2025 meta-analysis found that current evidence does not support NMN or NR as effective interventions for improving muscle mass or function in adults over 60.

Cancer prevention or treatment: While NAD+ metabolism is relevant to cancer biology, using NAD+ precursors in the context of cancer is extremely complex and potentially risky, as cancer cells also benefit from increased NAD+ availability. This is an area where supplementation should only occur under medical supervision.

The Honest Assessment

#

NAD+ precursor supplementation is a biologically plausible intervention with a growing but still modest body of human evidence. The supplements appear safe, they do raise NAD+ levels, and they produce some measurable improvements in specific biomarkers. But the notion that popping an NMN or NR capsule will dramatically slow your aging process is not supported by the current data.

The most responsible way to think about these supplements is as one potentially useful component of a broader longevity strategy that includes exercise, dietary optimization, sleep hygiene, stress management, and appropriate medical care.

Other NAD+ Boosting Strategies You Should Know About

#

Before spending $50-100 per month on NAD+ supplements, it is worth understanding that several free or inexpensive strategies also boost NAD+ levels, and some of them may be more effective than supplementation.

Exercise

#

Exercise is arguably the most potent NAD+ booster available. Research shows that athletes have approximately twice the NAMPT expression (the rate-limiting enzyme in NAD+ biosynthesis) in their musculature compared to sedentary individuals. In one study, previously sedentary individuals who began a stationary bike exercise protocol increased NAMPT levels by 127% within just three weeks.

High-intensity interval training (HIIT) appears to be particularly effective at boosting NAD+ levels, though regular moderate-intensity exercise including walking, cycling, and swimming also supports NAD+ homeostasis.

Exercise activates AMPK and increases NAMPT expression through mechanisms that supplements cannot replicate. If you are considering NAD+ supplementation but are not exercising regularly, starting an exercise program would likely provide greater overall benefits.

Intermittent Fasting and Caloric Restriction

#

Caloric restriction was the original intervention shown to activate sirtuins, and this activation is mediated in part through increased NAD+ levels. Intermittent fasting triggers AMPK activation, which stimulates NAD+ production. Common fasting protocols include 16:8 (16 hours fasting, 8 hours eating) and periodic 24-hour fasts.

David Sinclair’s lab was among the first to demonstrate that sirtuins are activated by caloric restriction in mammals, and much of the interest in NAD+ supplementation stems from the desire to replicate the benefits of caloric restriction without the discomfort of actually eating less.

Niacin (Vitamin B3)

#

Niacin is the oldest, cheapest, and most thoroughly studied NAD+ precursor. A study published in Cell Metabolism in 2020 showed that niacin supplements increased blood NAD+ levels up to 8-fold, a larger increase than typically reported for NMN or NR. Niacin costs pennies per serving compared to dollars for NMN and NR.

The catch is flushing. Niacin causes prostaglandin-mediated vasodilation that produces uncomfortable skin flushing, warmth, and itching, typically 20-30 minutes after ingestion. This side effect significantly limits adherence. Extended-release niacin formulations reduce flushing but carry some hepatotoxicity risk at high doses. Nicotinamide (niacinamide) does not cause flushing but is less effective at raising NAD+ and may inhibit sirtuin activity at high doses.

Dietary Sources

#

Foods naturally rich in NAD+ precursors include:

• Milk: Contains measurable amounts of NR
• Fish and poultry: Rich in niacin and tryptophan
• Mushrooms: Contain niacin
• Green vegetables, particularly edamame and broccoli: Contain small amounts of NMN
• Whole grains: Contain niacin

While dietary sources alone are unlikely to dramatically boost NAD+ levels, they contribute to the overall NAD+ precursor pool and support general metabolic health.

Resveratrol and Polyphenols

#

Resveratrol and other polyphenols found in grapes, blueberries, and dark chocolate may support NAD+ metabolism indirectly by activating sirtuins and stimulating AMPK. David Sinclair takes resveratrol alongside NMN in his personal supplement protocol. However, the evidence for resveratrol’s benefits in humans is mixed, and its bioavailability is notoriously poor without specific formulation strategies.

CD38 Inhibitors

#

Since CD38 is the primary enzyme responsible for age-related NAD+ decline, inhibiting CD38 could theoretically preserve NAD+ levels more effectively than flooding the system with precursors. Some natural compounds, including apigenin (found in parsley and chamomile), quercetin, and luteolin, have shown CD38-inhibitory activity in preclinical studies. This approach is scientifically interesting but remains early-stage.

Cost Comparison: NMN vs NR

#

Cost is a practical reality that affects the sustainability of any supplement protocol, and NAD+ precursors are not cheap.

NMN Pricing

#

High-quality NMN products typically range from $30 to $100+ per bottle, depending on dose, purity, and brand reputation. At a 500 mg daily dose, expect to spend approximately:

• Budget options (unverified quality): $0.50-$1.00 per day ($15-$30/month)
• Mid-range (established brands with some testing): $1.00-$2.00 per day ($30-$60/month)
• Premium (third-party tested, liposomal): $2.00-$3.50 per day ($60-$105/month)

Be immediately suspicious of NMN products priced significantly below market average. Producing pharmaceutical-grade NMN involves substantial manufacturing costs, and extremely low prices almost always indicate counterfeit or severely diluted products.

NR Pricing

#

NR is generally priced in a similar range to NMN, though the market is somewhat more consolidated around ChromaDex’s Niagen:

• Tru Niagen (300 mg/day): Approximately $40-$50 per month
• Tru Niagen (600 mg/day, two capsules): Approximately $80-$100 per month
• Generic NR formulations: $30-$60 per month (quality varies significantly)

Niacin Pricing (For Comparison)

#

Regular niacin supplements cost approximately $5-$15 per month, making them roughly 5-10 times cheaper than NMN or NR. While the flushing side effect is a significant limitation, the cost difference is worth considering for budget-conscious consumers.

Value Considerations

#

When evaluating cost, consider:

1. Verified potency: A cheap NMN product that contains no actual NMN (as independent testing has found in many products) provides zero value regardless of price.
2. Clinical dose alignment: Products dosed below clinically studied levels may not provide meaningful benefits.
3. Duration of commitment: NAD+ levels return to baseline within about a month of stopping supplementation, so this is an ongoing expense.
4. Opportunity cost: The same money spent on a gym membership, higher-quality food, or better sleep hygiene might provide greater longevity benefits than supplementation alone.

Side Effects and Safety Profile

#

Both NMN and NR have demonstrated favorable safety profiles in clinical trials, but understanding the known risks and uncertainties is important.

NMN Side Effects

#

In published clinical trials, NMN has been well tolerated at doses up to 1,250 mg/day for 4 weeks and at lower doses for up to 12 weeks. The most commonly reported side effects are mild and include:

• Mild gastrointestinal discomfort (nausea, bloating)
• Headache (infrequent)
• Skin flushing (rare, much less common than with niacin)

No serious adverse events have been attributed to NMN supplementation in any published human trial.

NR Side Effects

#

NR has been tested at doses up to 2,000 mg/day for extended periods with a similarly mild side effect profile:

• Mild gastrointestinal symptoms (nausea, diarrhea, stomach discomfort)
• Headache
• Fatigue (paradoxically, in some individuals)
• Skin flushing (rare)

ChromaDex’s safety dossier for Niagen includes extensive preclinical and clinical safety data supporting long-term use at recommended doses.

Shared Safety Considerations

#

Methylation concerns: Both NMN and NR are metabolized through pathways that consume methyl groups. High-dose, long-term NAD+ precursor supplementation could theoretically deplete methyl donors like SAMe and folate. Some practitioners recommend supplementing with methylated B vitamins (methylfolate, methylcobalamin) alongside NAD+ precursors, though clinical evidence of methylation depletion from standard supplement doses is limited.

Cancer considerations: NAD+ supports cellular energy production in all cells, including cancer cells. Some researchers have raised theoretical concerns that boosting NAD+ in individuals with undetected cancers could potentially fuel tumor growth. This concern remains theoretical, and no clinical trial has demonstrated increased cancer risk from NMN or NR supplementation. However, individuals with active malignancies or a history of cancer should discuss NAD+ supplementation with their oncologist.

Drug interactions: No significant drug interactions have been identified in clinical trials, but NMN and NR could theoretically interact with medications that affect NAD+ metabolism, including certain chemotherapy agents and PARP inhibitors used in cancer treatment.

Pregnancy and breastfeeding: There is insufficient data on NMN or NR supplementation during pregnancy or breastfeeding. These supplements should be avoided during these periods unless directed by a healthcare provider.

Product Recommendations: What to Look For

#

Given the quality issues discussed above, choosing the right product requires careful evaluation. Here are practical considerations for each compound.

For NMN Supplementation

#

When selecting an NMN product, prioritize:

• Purity of 98% or higher with third-party verification from a recognized testing organization
• Dosing between 250-500 mg per serving to align with clinically studied doses
• Manufacturing in GMP-certified facilities with documented quality control processes
• Transparent certificates of analysis from independent laboratories (not just the manufacturer’s in-house testing)
• Stable formulation that protects NMN from degradation (look for opaque packaging, desiccant packets, and appropriate storage instructions)

Some well-regarded NMN brands include those that provide batch-specific certificates of analysis, use enzymatic synthesis rather than chemical synthesis, and have consistent positive results in independent testing.

For NR Supplementation

#

For NR products, the choice is somewhat simpler:

• Look for the Niagen trademark on the product label, which indicates ChromaDex-supplied NR with verified purity and potency
• Standard dosing of 300 mg per capsule, with protocols for 1-3 capsules daily
• Tru Niagen is ChromaDex’s direct-to-consumer brand and the most straightforward way to get verified NR
• Life Extension NAD+ Cell Regenerator and similar products from established supplement companies also use Niagen NR

Combination Products

#

Some products combine NMN or NR with complementary ingredients like:

• Resveratrol or pterostilbene: Sirtuin activators that may work synergistically with NAD+ precursors
• TMG (trimethylglycine): A methyl donor that may help offset potential methylation depletion
• Quercetin or apigenin: Natural CD38 inhibitors that could help preserve NAD+ levels
• BioPerine (piperine): A bioavailability enhancer shown to improve NMN absorption in at least one clinical study

These combinations are theoretically sensible but have generally not been tested as formulations in rigorous clinical trials.

The Verdict: NMN vs NR - Which Should You Choose?

#

After reviewing the biochemistry, the clinical evidence, the regulatory landscape, and the practical considerations, here is our honest assessment.

NMN Advantages

#

• One fewer enzymatic step to NAD+ (does not require NRK phosphorylation)
• Potential for direct cellular uptake via the Slc12a8 transporter in certain tissues
• Some comparative data suggesting a larger NAD+ increase at equivalent doses
• Heavily researched by David Sinclair’s lab at Harvard, lending scientific credibility
• Now FDA-cleared for use in dietary supplements (as of September 2025)
• Growing body of positive human clinical trials

NMN Disadvantages

#

• Severe quality and purity problems in the market (majority of tested products fail potency standards)
• History of regulatory uncertainty that disrupted supply chains
• Larger molecule that may face bioavailability challenges
• Significant portion is deamidated by gut microbiota before absorption
• Fewer published human clinical trials than NR

NR Advantages

#

• Longer track record of published human clinical trials
• ChromaDex’s Niagen provides a standardized, quality-controlled form
• GRAS status and proactive regulatory compliance
• Smaller molecule with established membrane transport mechanisms
• Well-characterized safety profile across multiple long-term studies
• More consistent product quality due to patent-protected manufacturing

NR Disadvantages

#

• Requires additional enzymatic step (NRK phosphorylation) before conversion to NAD+
• ChromaDex’s patent protection means limited competition and potentially higher prices
• Some comparative data suggesting a smaller NAD+ increase than NMN at equivalent doses
• Subject to degradation by purine nucleoside phosphorylase

Our Assessment

#

If product quality and regulatory certainty are your top priorities, NR (specifically Niagen/Tru Niagen) has the edge. The standardized manufacturing, GRAS status, and extensive clinical trial program provide a level of confidence that the NMN market generally cannot match.

If you are willing to do the work of verifying product quality and you prioritize the theoretical biochemical advantages, NMN may produce slightly larger increases in NAD+ levels. But this only matters if you are actually getting genuine, high-purity NMN, which independent testing suggests is not the case for most products on the market.

For most consumers, the choice between a verified NR product and a verified NMN product is likely to produce similar real-world outcomes. Both raise NAD+ levels, both appear safe, and neither has yet demonstrated dramatic anti-aging effects in humans.

The most important factor is not which precursor you choose but whether the product you buy actually contains what it claims.

Common Questions About Nmn

#

What are the benefits of nmn?

Nmn has been studied for various potential health benefits. Research suggests it may support several aspects of health and wellness. Individual results can vary. The strength of evidence differs across different claimed benefits. More high-quality research is often needed. Always review the latest scientific literature and consult healthcare professionals about whether nmn is right for your health goals.

Is nmn safe?

Nmn is generally considered safe for most people when used as directed. However, individual responses can vary. Some people may experience mild side effects. It’s important to talk with a healthcare provider before using nmn, especially if you have existing health conditions, are pregnant or nursing, or take medications.

How does nmn work?

Nmn works through various biological mechanisms that researchers are still studying. Current evidence suggests it may interact with specific pathways in the body to produce its effects. Always consult with a healthcare provider before starting any new supplement or health regimen to ensure it’s appropriate for your individual needs.

Who should avoid nmn?

Nmn is a topic of ongoing research in health and nutrition. Current scientific evidence provides some insights, though more studies are often needed. Individual responses can vary significantly. For personalized advice about whether and how to use nmn, consult with a qualified healthcare provider who can consider your complete health history and current medications.

What are the signs nmn is working?

Nmn is a topic of ongoing research in health and nutrition. Current scientific evidence provides some insights, though more studies are often needed. Individual responses can vary significantly. For personalized advice about whether and how to use nmn, consult with a qualified healthcare provider who can consider your complete health history and current medications.

How long should I use nmn?

The time it takes for nmn to work varies by individual and depends on factors like dosage, consistency of use, and individual metabolism. Some people notice effects within days, while others may need several weeks. Research studies typically evaluate effects over weeks to months. Consistent use as directed is important for best results. Keep a journal to track your response.

Frequently Asked Questions

#

Can I take NMN and NR together?

There is no published clinical evidence evaluating the combination of NMN and NR in humans. Since both are converted to NAD+ through overlapping pathways, taking both simultaneously is unlikely to provide additive benefits beyond what a sufficient dose of either alone would provide. You would likely be better served by optimizing the dose of one compound rather than splitting your budget between both.

How do I know if NAD+ supplementation is working?

Short of blood testing for NAD+ metabolites (which some specialty labs now offer), subjective indicators like improved energy levels, better sleep quality, and enhanced exercise recovery are the most practical markers. However, these are highly susceptible to placebo effects. If you want objective data, companies like Jinfiniti offer NAD+ blood testing that can measure your baseline and post-supplementation levels.

Does David Sinclair still take NMN?

As of his most recent public statements, David Sinclair continues to take 1 gram (1,000 mg) of NMN daily, along with resveratrol, metformin, and other supplements as part of his longevity protocol. He has reported that his blood biomarkers at age 59 approximate those of a 31-year-old, though these claims have not been independently verified in a controlled study, and his results (if accurate) cannot be attributed to any single supplement in his complex regimen.

At what age should you start taking NAD+ precursors?

There is no consensus on when to begin supplementation. NAD+ levels begin declining gradually from young adulthood onward, with more significant declines typically apparent by ages 40-50. Most clinical trials have enrolled participants aged 40 and older. For younger adults, the benefits of supplementation are less clear, and the investment in exercise, diet, and sleep may provide greater returns.

Are there any foods that naturally contain NMN or NR?

Yes, but in very small quantities. Broccoli, edamame, avocado, and cucumber contain trace amounts of NMN. Milk contains measurable amounts of NR. However, the quantities in food are orders of magnitude below the doses used in clinical trials (you would need to eat hundreds of kilograms of broccoli to get a clinical dose of NMN), making dietary intake largely irrelevant for therapeutic purposes.

References

#

1. Yoshino M, et al. “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.” Science. 2021;372(6547):1224-1229. doi:10.1126/science.abe9985

2. Imai SI, Guarente L. “NAD+ and sirtuins in aging and disease.” Trends in Cell Biology. 2014;24(8):464-471. doi:10.1016/j.tcb.2014.04.002

3. Camacho-Pereira J, et al. “CD38 dictates age-related NAD decline and mitochondrial dysfunction through a SIRT3-dependent mechanism.” Cell Metabolism. 2016;23(6):1127-1139. doi:10.1016/j.cmet.2016.05.006

4. Yoshino J, Baur JA, Imai SI. “NAD+ intermediates: The biology and therapeutic potential of NMN and NR.” Cell Metabolism. 2018;27(3):513-528. doi:10.1016/j.cmet.2017.11.002

5. Martens CR, et al. “Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.” Nature Communications. 2018;9(1):1286. doi:10.1038/s41467-018-03421-7

6. Elhassan YS, et al. “Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures.” Cell Reports. 2019;28(7):1717-1728. doi:10.1016/j.celrep.2019.07.043

7. Grozio A, et al. “Slc12a8 is a nicotinamide mononucleotide transporter.” Nature Metabolism. 2019;1(1):47-57. doi:10.1038/s42255-018-0009-4

8. Ratajczak J, et al. “NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells.” Nature Communications. 2016;7:13103. doi:10.1038/ncomms13103

9. Yi L, et al. “The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.” GeroScience. 2023;45(1):29-43. doi:10.1007/s11357-022-00705-1

10. Huang H. “A multicentre, randomised, double blind, parallel design, placebo controlled study to evaluate the efficacy and safety of Uthever (NMN supplement), an orally administered supplementation in middle aged and older adults.” Frontiers in Aging. 2022;3:851698. doi:10.3389/fragi.2022.851698

11. Irie J, et al. “Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.” Endocrine Journal. 2020;67(2):153-160. doi:10.1507/endocrj.EJ19-0313

12. Fukamizu Y, et al. “Safety evaluation of beta-nicotinamide mononucleotide oral administration in healthy adult men and women.” Scientific Reports. 2022;12(1):14442. doi:10.1038/s41598-022-18272-y

13. Dollerup OL, et al. “A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects.” American Journal of Clinical Nutrition. 2018;108(2):343-353. doi:10.1093/ajcn/nqy132

14. Pencina KM, et al. “Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial.” Nature Communications. 2024;15:5093. doi:10.1038/s41467-024-49092-5

15. Yang H, et al. “An updated review on the mechanisms, pre-clinical and clinical comparisons of nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR).” Food Frontiers. 2025. doi:10.1002/fft2.511

16. Chini EN. “CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.” Current Pharmaceutical Design. 2009;15(1):57-63. doi:10.2174/138161209787185788

17. Verdin E. “NAD+ in aging, metabolism, and neurodegeneration.” Science. 2015;350(6265):1208-1213. doi:10.1126/science.aac4854

18. Conze D, Brenner C, Kruger CL. “Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults.” Scientific Reports. 2019;9(1):9772. doi:10.1038/s41598-019-46120-z

19. Liu Y, et al. “The effect of nicotinamide mononucleotide and riboside on skeletal muscle mass and function: a systematic review and meta-analysis.” Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.13755

20. U.S. Food and Drug Administration. “FDA confirms NMN is lawful in dietary supplements.” September 29, 2025.

Related Articles

#

• Resveratrol Benefits and Dosing: What the Anti-Aging Research Actually Shows
• Best NAD+ Supplements: NMN, NR, and Other NAD Boosters Reviewed
• Spermidine for Longevity and Autophagy: What the Emerging Research Shows

Where to Buy Quality Supplements

#

Based on the research discussed in this article, here are some high-quality options:

• Magnesium Supplement
• Protein Supplement